Delivery Order SPE2DB22D3501-SPE2DB25FXM48
Award Date 9/23/25
Potential Completion Date 10/15/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 180 mg vials of Trodelvy, a specialty oncology medication, valued at $9,584.58 with a firm fixed price structure. The award, issued on September 22, 2025, carries an ultimate completion date of October 14, 2025, and represents a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on September 22, 2025, by the Defense Logistics Agency Medical Supply Chain to supply one vial of Trodelvy 180mg, a oncology therapeutic medication, for delivery to Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with a ceiling value of $19,169.16 and an ultimate completion date of September 23, 2025. No set-aside designation was applied to this competitive award, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,974.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 mg vials of Trodelvy, a specialty pharmaceutical product. The award was made competitively with no set-aside designation and carries an ultimate completion date of October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same municipality. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,974.30 on August 25, 2025, for 180 mg vials of Trodelvy, a specialty oncology pharmaceutical. The contract is not set-aside and utilizes firm fixed pricing, with an ultimate completion date of September 16, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with the Defense...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $9,584.58 to supply Trodelvy 180 mg vials, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trodelvy 180 mg vials, a specialty pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $9,584.58 and is scheduled for completion by October 15, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a $9,584.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trodelvy 180 mg vials, with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $9,584.58 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Trodelvy 180 mg vials. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded without a set-aside...
- The Defense Logistics Agency awarded a $22,364.02 delivery order to AmerisourceBergen Drug Corp for 180 mg vials of Trodelvy, a pharmaceutical product for medical supply distribution. This competitively awarded, non-set-aside contract operates under firm fixed pricing with a completion deadline of October 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Trodelvy 180 mg vials, a cancer treatment medication. This firm fixed-price delivery order, valued at $15,974.30, is scheduled for completion by August 7, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting the...